Combination of canagliflozin and adagrasib as a novel targeted therapy for LKB1-KRASG12C co-mutated NSCLC

Cancer Letters · Elsevier

Аннотация

Publication date: 28 December 2026 Source: Cancer Letters, Volume 663 Author(s): Xiang-Zheng Gao, Yiguan Chen, Liangliang Gao, Dade Rong, Mingzhu Tang, Haimei Tang, Yichi Zhang, Liming Xie, Yuheng Qin, Shuai You, Jingyao Wang, Guang Lu, Zhi-Qiang Ling, Han-Ming Shen

Читать у издателя →

Похожие статьи